In the central amygdala (CeA), ethanol acts via corticotrophinreleasing factor (CRF) type 1 receptors to enhance GABA release. Amygdala CRF mediates anxiety associated with stress and drug dependence, and it regulates ethanol intake. Because mutant mice that lack PKC exhibit reduced anxiety-like behavior and alcohol consumption, we investigated whether PKC lies downstream of CRF1 receptors in the CeA. Compared with PKC ؉/؉ CeA neurons, PKC ؊/؊ neurons showed increased GABAergic tone due to enhanced GABA release. CRF and ethanol stimulated GABA release in the PKC ؉/؉ CeA, but not in the PKC ؊/؊ CeA. A PKC-specific inhibitor blocked both CRF-and ethanol-induced GABA release in the PKC ؉/؉ CeA, confirming findings in the PKC ؊/؊ CeA. These results identify a PKC signaling pathway in the CeA that is activated by CRF 1 receptor stimulation, mediates GABA release at nerve terminals, and regulates anxiety and alcohol consumption.
T he neuropeptide corticotrophin-releasing factor (CRF) contributes to stress-related disorders such as anxiety and depression. Elevated levels of CRF are commonly found in the cerebrospinal fluid of patients suffering from depression or anxiety disorders (1, 2) . Moreover, intracerebroventricular infusion of CRF or transgenic overexpression of CRF increases anxiety-like behavior in rodents (3, 4) . The anxiogenic effects of CRF are mediated by type 1 CRF receptors (CRF 1 Rs), as demonstrated in CRF 1 R-deficient mice, which show reduced anxiety-like behavior (5, 6) . CRF 1 Rs are abundantly expressed in the cortex, cerebellum, hippocampus, amygdala, olfactory bulb, and pituitary (7) (8) (9) . Of particular interest is the amygdala, a pivotal region in the acquisition and expression of fear conditioning (10) . In the rat, intra-amygdalar injections of CRF increase inhibitory avoidance responses while reducing exploratory behavior in an open field (11) . In addition, injection of CRF antagonists and CRF 1 R antisense oligonucleotides into the rat amygdala reduces stress-induced, anxiety-like behavior (12, 13) . Thus, CRF expression in the amygdala is especially critical in the regulation of anxiety.
Prolonged alcohol dependence produces a negative emotional state characterized by heightened anxiety and reactivity to stress, which increases alcohol drinking, probably in an attempt to relieve these negative symptoms (14) . Recent evidence suggests that this negative affective state is regulated by extrahypothalamic CRF. CRF release in the central amygdala (CeA) and bed nucleus of the stria terminalis (BNST) is increased in alcoholdependent animals (15, 16) and appears to contribute to alcohol withdrawal-related anxiety, which can be reduced by CRF receptor antagonists injected into the CeA (17) . CRF also contributes to increased alcohol consumption in dependent animals because their increased ethanol self-administration is reduced by CRF 1 receptor antagonists (18) or the deletion of the CRF 1 R (19) .
CRF is abundant in the CeA, where it is coexpressed with GABA (20) , suggesting that CRF may modulate GABAergic signaling within the amygdala. Most of the CeA neurons in rodents are GABAergic inhibitory neurons with inhibitory recurrent or feed-forward connections, as well as inhibitory projections to brainstem nuclei (see Fig. 1 ) (21, 22) . We previously showed that CRF and ethanol enhance GABA release from mouse CeA neurons in a CRF 1 R-dependent manner (23) . This finding suggested a cellular mechanism by which CRF could modulate the behavioral and motivational effects of ethanol. CRF acting at CRF 1 Rs may also regulate alcohol drinking in humans because variants in the CRHR1 gene encoding the human CRF 1 R have recently been associated with binge drinking and high alcohol intake in two independent sample populations (24).
It is not known how activation of CRF 1 Rs in the amygdala influence anxiety and alcohol drinking. However, recent in vitro evidence indicates that PKC signaling is stimulated by CRF 1 R activation (25, 26) . PKC is a family of serine-threonine kinases that respond to lipid second messengers and have been implicated in neurobehavioral disorders, including anxiety and drug abuse (27) . Among the PKC isozymes, we hypothesized that PKC mediates downstream effects of CRF 1 R activation in the CeA because PKC is expressed throughout the amygdala (28) and PKC Ϫ/Ϫ mice show reduced anxiety-like behavior (29) and reduced alcohol consumption (30, 31) . To examine this hypothesis, we studied the role of PKC signaling in basal CeA GABAergic transmission and in ethanol-and CRF-induced GABA release in an in vitro slice preparation using both genetic and pharmacological approaches. Our findings indicate that PKC is a key regulator of basal and of CRF-and ethanol-stimulated GABA release from CeA neurons.
Results
Basal GABAergic Transmission Is Enhanced in CeA Neurons from PKC ؊/؊ Mice. We recorded from 118 CeA neurons with a mean resting membrane potential of Ϫ76 Ϯ 2 mV and a mean input resistance of 106 Ϯ 4 ⌴⍀. PKC Ϫ/Ϫ and PKC ϩ/ϩ littermates did not show significant differences in these properties. We evoked pharmacologically isolated GABA A receptor-mediated IPSPs (GABA A IPSPs) by stimulating locally within the CeA. Interestingly, baseline IPSP input-output (I-O) curves generated by equivalent stimulus intensities were higher in CeA neurons from PKC Ϫ/Ϫ mice compared with those from littermates ( Fig. 2A) . To test whether this synaptic enhancement could derive from a presynaptic site of action, we examined paired-pulse facilitation (PPF) of the IPSPs at 50-, 100-, and 200-msec interstimulus intervals (ISIs). Generally, changes in PPF are inversely related to transmitter release (32, 33) . When compared with the ratio from littermate wild-type controls (Fig. 2B) , we found that the baseline PPF ratio of IPSPs was decreased in CeA neurons from PKC Ϫ/Ϫ mice, suggesting that GABA release was augmented in the CeA of PKC Ϫ/Ϫ mice. To further characterize the increased GABA release in PKC Ϫ/Ϫ mice, we recorded pharmacologically isolated spontaneous miniature GABA A IPSCs (mIPSCs) using whole-cell patch clamp in the presence of 1 M TTX to eliminate action potential-dependent neurotransmitter release. Notably, the mean baseline frequency of mIPSCs was greater in CeA neurons from PKC Ϫ/Ϫ mice compared with neurons from PKC ϩ/ϩ littermates ( Fig. 2C) , suggesting increased basal GABA release in the CeA of PKC Ϫ/Ϫ mice. In contrast, the mean amplitude of mIPSCs was similar in PKC Ϫ/Ϫ and PKC ϩ/ϩ CeA neurons (Fig. 2D) , indicating no significant difference between the two genotypes in postsynaptic GABA A receptor activation by spontaneously released GABA. Also, we did not observe differences in decay time or rise time of basal mIPSCs in CeA neurons from PKC Ϫ/Ϫ and PKC ϩ/ϩ mice (data not shown). (Fig. 3A) . To test whether the site of CRF action was preor postsynaptic, we examined the effect of CRF on PPF of the IPSPs at 50-, 100-, and 200-msec ISIs and found that CRF decreased the PPF of IPSPs (Fig. 3B) at 50-and 100-msec ISIs, suggesting that CRF acts presynaptically to increase GABA release in the mouse CeA. We then examined neurons from PKC Ϫ/Ϫ mice to investigate whether PKC is required for CRF-stimulated GABA release. Unlike CeA neurons from PKC ϩ/ϩ mice, CRF-induced enhancement of evoked IPSP amplitude was absent in neurons from PKC Ϫ/Ϫ mice (Fig. 3C ).
In addition, CRF did not alter the PPF ratio of IPSPs at any of the three ISIs tested (Fig. 3D ).
To further verify the presynaptic site of CRF action, we also evaluated the effect of CRF on mIPSCs. Superfusion of 200 nM CRF onto PKC ϩ/ϩ CeA neurons increased the mean frequency of mIPSCs and shifted the cumulative frequency distribution to shorter interevent intervals ( Fig. 4 A and E), supporting the PPF data indicating increased presynaptic release of GABA by CRF. These mIPSCs were completely blocked by superfusion of bicuculline (data not shown), indicating their mediation by GABA A receptors. CRF did not significantly alter mIPSC amplitudes (Fig. 4C) . Notably, in contrast to CeA neurons of 
PKC
ϩ/ϩ mice, CRF decreased mean mIPSC frequency in neurons from PKC Ϫ/Ϫ mice ( Fig. 4 B and E), suggesting that CRF decreases vesicular GABA release in PKC Ϫ/Ϫ neurons. As in the CeA of PKC ϩ/ϩ mice, CRF did not affect the mean amplitude of mIPSCs in the CeA of PKC Ϫ/Ϫ mice (Fig. 4 D and  F) , again indicating the lack of postsynaptic CRF effects on GABA A receptor stimulation by GABA in the mouse CeA.
Because developmental changes or compensatory effects of other gene products may confound studies in gene-targeted mice, we pharmacologically confirmed the role of PKC in regulating GABA release from CeA neurons by using a PKC inhibitor peptide, Tat-V1-2 (34). Superfusion of the inhibitor alone (500 nM) onto slices from PKC ϩ/ϩ mice increased the mean evoked IPSP amplitude and decreased the PPF of IPSPs in CeA neurons [supporting information (SI) Fig. S1 A and B] . These results suggest a constitutive role for PKC in tonically inhibiting GABA release at CeA synapses that may account, in part, for increased basal GABAergic transmission seen in PKC Ϫ/Ϫ mice. Moreover, pretreatment of CeA neurons with the Tat-V1-2 peptide blocked the CRF-induced augmentation of the evoked IPSP amplitudes (Fig. S1 B and C) and prevented the CRF-induced decrease in PPF of IPSPs (Fig. S1D) . These results resemble those obtained in CeA neurons from PKC Ϫ/Ϫ mice ( Fig. 3 C and D) and support the conclusion that PKC mediates CRF activation of GABA release.
Ethanol Enhancement of GABAergic Transmission Is Blocked in CeA
from PKC ؊/؊ Mice. Previously, we found that ethanol dosedependently increased GABAergic transmission in CeA slices by increasing GABA release through a mechanism dependent on the activation of CRF 1 Rs (23, 33) . Having determined that CRFinduced GABA release is regulated by PKC, we investigated whether ethanol-stimulated GABA release also involves PKC. In CeA slices from PKC ϩ/ϩ mice, 10-min superfusion of 44 mM ethanol increased the mean amplitude of evoked IPSPs by 47% at each stimulus strength tested (n ϭ 19) (Fig. 5A) . Ethanol also significantly decreased the PPF of IPSPs (Fig. 5B) at each ISI, suggesting that ethanol increases GABA release. Next, we examined neurons from PKC Ϫ/Ϫ mice to investigate whether PKC is required for ethanol-stimulated GABA release. Notably, in contrast to PKC ϩ/ϩ neurons ( Fig. 5 A and B) , the ethanol-induced augmentation of evoked IPSP amplitudes was completely absent in CeA neurons from PKC Ϫ/Ϫ mice (Fig. 5C) , as was the ethanolinduced reduction in PPF of IPSPs (Fig. 5D) . To further verify the presynaptic site of ethanol action, we also evaluated the effect of ethanol on mIPSCs in the CeA. Ethanol, like CRF, increased the mean frequency of mIPSCs and shifted the cumulative frequency distribution to shorter interevent intervals in PKCe ϩ/ϩ CeA neurons ( Fig. 6 A and E), supporting PPF data indicating an increased release of GABA by ethanol. Ethanol, like CRF, did not significantly alter the mIPSC amplitudes ( Fig. 6 C and F) . In sharp contrast to CeA neurons of PKC ϩ/ϩ littermates, ethanol significantly (P Ͻ 0.05, two-tailed t test) decreased the mean mIPSC frequency in CeA neurons from PKC Ϫ/Ϫ mice ( Fig. 6 B and E) , suggesting that ethanol actually decreases vesicular GABA release in these neurons. As in PKC ϩ/ϩ neurons, ethanol did not affect the mean amplitude of mIPSCs in PKC Ϫ/Ϫ neurons ( Fig. 6 D and F) , again indicating lack of postsynaptic ethanol effects on GABA A receptor activation by synaptically released GABA in the mouse CeA.
To further demonstrate the involvement of PKC in ethanol effects on CeA neurons, we superfused the Tat-V1-2 peptide (500 nM) onto another group of PKC ϩ/ϩ CeA neurons for 30 min before superfusion of ethanol in the continued presence of Tat-V1-2. Pretreatment with the Tat-V1-2 peptide completely abolished the ethanol-induced increase in IPSP amplitudes ( Fig. S1 B and C) . Instead, ethanol actually significantly decreased (P Ͻ 0.05) the evoked IPSP amplitudes in the presence of the PKC inhibitor. In addition, the Tat-V1-2 peptide blocked the ethanol-induced decrease in PPF of IPSPs (Fig.   S1D ). These results confirm that PKC mediates ethanol enhancement of evoked GABA release in the CeA.
Discussion
Recent evidence indicates that PKC can be activated by CRF signaling in the nervous system. PKC contributes to CRFmediated long-term depression of climbing fiber-parallel fiber synapses in the cerebellum (35) and to CRF-stimulated neuronal activity in hippocampal slices from BALB/c mice (36) . In AtT-20 cells, CRF acting at CRF 1 Rs increases CREB phosphorylation through a PKC-dependent mechanism (25) , whereas in MN9D dopaminergic cells, CRF 1 R activation produces a PKCdependent inhibition of T-type calcium channels (26) . However, the PKC isozymes that mediate these CRF responses are not known. Here we demonstrate a specific role for the PKC in CRF-stimulated GABA release from neurons of the CeA. Moreover, consistent with our previous observation that ethanol-induced GABA release in the amygdala is CRF 1 Rdependent (23), here we also find that ethanol-stimulated vesicular GABA release depends on PKC. Taken together, these findings indicate a signaling pathway whereby CRF, acting at presynaptic CRF 1 Rs in the amygdala, activates PKC to stimulate GABA release. Because CRF is anxiogenic and plays an important role in promoting alcohol drinking (14) , disturbance of this CRF 1 R-PKC signaling pathway in the CeA likely contributes to decreased anxiety-like behavior and decreased alcohol consumption in PKC Ϫ/Ϫ mice.
Without drug treatment, evoked GABA A IPSPs were larger, paired-pulse facilitation of IPSPs was reduced, and the frequency of mIPSCs was higher in PKC Ϫ/Ϫ neurons when compared with PKC ϩ/ϩ neurons. This finding suggests a basal level of CRF 1 R activation or PKC activity in wild-type neurons that serves to limit spontaneous GABA release. Both CRF and ethanol increased evoked IPSP amplitudes, decreased pairedpulse facilitation of IPSPs, and increased the frequency of spontaneous mIPSCs in PKC ϩ/ϩ neurons, but not in PKC Ϫ/Ϫ neurons, indicating that under drug-stimulated conditions PKC facilitates vesicular GABA release. The inability of ethanol and CRF to stimulate release in PKC Ϫ/Ϫ mice was not due to a ceiling effect because both agents actually diminished evoked IPSP amplitudes in the presence of a PKCe inhibitor by 5-10% and decreased the frequency of spontaneous mIPSCs in PKC Ϫ/Ϫ neurons by Ϸ25% from baseline. Therefore, these results indicate that PKC serves two roles in the CeA: (i) reduce spontaneous baseline GABA release, and (ii) mediate CRF-and ethanol-stimulated release of GABA.
As schematized in Fig. 1 , most of the CeA neurons are GABAergic with inhibitory projections to brainstem nuclei. Because GABAergic drugs are typically robust anxiolytics (37) , it may seem paradoxical that CRF would augment GABAergic transmission in a brain region known to be involved in stress-related behavior. However, we find that anxiolytic agents like nociceptin (38) , endocannabinoids, and NPY diminish IPSPs in CeA neurons, whereas anxiogenic agents such as CRF (23) and galanin augment IPSPs in CeA neurons. Therefore, CRF 1 Rs and their linkage to PKC may modulate inhibitory CeA gating that regulates information flow through intra-amygdala circuits. By decreasing GABA release at nerve terminals of amygdala projection neurons, this signaling pathway could decrease the inhibition of downstream targets such as the BNST, thereby disinhibiting (i.e., exciting) these areas. Thus, the dogma of an inverted relationship between GABA and anxiety may apply to GABA's effects in these target areas, but not to its actions within the CeA.
It is important to note that our present findings represent only a subset of the actions of CRF and ethanol in the brain. In contrast to its presynaptic effects, we did not observe a direct postsynaptic effect of CRF or ethanol on membrane properties of CeA neurons. Because CRF and ethanol only increased evoked IPSP, but not mIPSC amplitudes, we can conclude that there is no direct effect of CRF or ethanol on GABA A receptors in the CeA per se.
Ethanol is anxiolytic when administered systemically, whereas amygdala CRF promotes anxiety-like behavior (14) . Given the parallel actions of ethanol and CRF in promoting GABA release within the CeA, these opposite behavioral responses may appear paradoxical. However, with respect to the CeA neuronal population we have studied, ethanol has more than one effect: It enhances GABA release, but also postsynaptically reduces NMDAR-and non-NMDAR-mediated glutamatergic excitatory postsynaptic potentials (39) , which could contribute to the anxiolytic effects of systemic ethanol. Additionally, in contrast to endogenous CRF, which is localized to specific brain circuits, systemic ethanol has a more global effect in enhancing GABAergic signaling in other brain regions involved in anxiety, such as those downstream of the CeA like the BNST, which also could explain the net anxiolytic effect of systemic ethanol (Fig. 1) .
In summary, a complete understanding of the cellular and molecular underpinnings of anxiety and drug abuse may require a region-by-region exploration of the many neuronal circuits shown to be involved in these behaviors. Nonetheless, our present findings indicate that PKC acting downstream of the CRF 1 R plays a pivotal role in the actions of two agents, CRF and ethanol, which are known to affect the GABA system in a brain region critically involved in stress-related behaviors such as anxiety and substance abuse.
Materials and Methods
Mouse Breeding and Care. We used PKC Ϫ/Ϫ mice previously generated by homologous recombination in J1 ES cells (40) . We conducted all mouse breeding and care procedures in accordance with the Ernest Gallo Clinic and Research Center and The Scripps Research Institute Institutional Animal Care and Use Committee (IACUC) policies.
Slice Preparation. We prepared CeA slices as previously described (23, 33) from male PKC Ϫ/Ϫ and PKC ϩ/ϩ littermates (5-6 months old at the time of experimentation). All electrophysiological experiments were performed in accordance with The Scripps Research Institute IACUC and National Institutes of Health guidelines on the care and use of laboratory animals. We cut 400-mthick transverse slices on a vibrating microtome (Vibratome Series 3000; Technical Products International), incubated them in an interface configuration for 30 min, and completely submerged and continuously superfused (flow rate of 2-4 ml/min) them with warm (31°C), gassed artificial cerebrospinal fluid (aCSF) of the following composition: 130 mM NaCl, 3.5 mM KCl, 1.25 mM NaH 2PO4, 1.5 mM MgSO4⅐7H2O, 2.0 mM CaCl2, 24 mM NaHCO3, and 10 mM glucose. Drugs were added to the aCSF from stock solutions to obtain known concentrations in the superfusate.
Electrophysiology of Evoked Responses.
For studies of evoked IPSPs, we recorded from CeA neurons with sharp micropipettes (3 M KCl) in current-clamp mode. We held most neurons near their resting membrane potential. We evoked pharmacologically isolated GABAA IPSPs by stimulating locally within the CeA through a bipolar stimulating electrode while superfusing the slices with the glutamate receptor blockers 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 10 M) and DL-2-amino-5-phosphonovalerate (APV; 30 M) and the GABA B receptor antagonist CGP 55845A (1 M). At the end of the recording, to confirm the GABAergic nature of the IPSPs, we superfused 30 M bicuculline or 50 M picrotoxin. These GABAA receptor antagonists completely blocked the IPSPs. To determine the stimulus-response parameters for each cell, we performed an I-O protocol (at least three times for each experimental condition at baseline, during drug administration, and during washout). We applied a range of manually adjusted currents (50 -250 A; 0.125 Hz), starting at the current required to elicit a threshold IPSP up to that required to elicit the maximal amplitude. We also applied hyperpolarizing and depolarizing voltage steps (200-pA increments, 750-msec duration) to generate voltagecurrent curves. Data were acquired with an Axoclamp-2A preamplifier and quantified by using the software package Clampfit 8.2 (Molecular Devices).
We examined PPF in each neuron by using 50-, 100-, and 200-msec ISIs (41). The stimulus strength was adjusted such that the amplitude of the first IPSP was 50% of maximum, as determined from the I-O relationship. We calculated the PPF ratio as the second IPSP amplitude divided by the amplitude of the first IPSP. All measures were taken before CRF or ethanol superfusion (control), during their superfusion (5-10 min), and after washout (20 -30 min) .
In experiments with the PKC peptide inhibitor Tat-V1-2 (34), we superfused 500 nM of the peptide onto CeA slices for Ϸ30 min before analysis of CRF and ethanol effects on IPSPs in the continued presence of Tat-V1-2.
Whole-Cell Patch-Clamp Recording of Miniature IPSCs. In a separate set of neurons, we recorded from the CeA by using the ''blind'' whole-cell patch-clamp method in the presence of 10 M CNQX, 30 M APV, 1 M CGP 55845A, and 1 M tetrodotoxin (TTX) to isolate spontaneous, action potential-independent, GABAergic mIPSCs. All GABA A mIPSC recordings were made by using pipettes (input resistance 2-3 M⍀) filled with an internal solution containing: 135 mM KCl, 10 mM Hepes, 2 mM MgCl 2, 0.5 mM EGTA, 5 mM ATP, and 1 mM GTP (the latter two added fresh on the day of recording) (pH 7.2-7.3, osmolarity 275-290 mOsm). Data were acquired with an Axoclamp-2A preamplifier (Molecular Devices) and were analyzed by using Mini 5.1 software (Synaptosoft).
